LICENSE AgreementLicense Agreement • March 15th, 2017 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • Delaware
This License Agreement (this “Agreement”) is made and entered into effective as of November 28, 2016 (the “Effective Date”) by and between Idera Pharmaceuticals, Inc., a Delaware corporation having a place of business at 167 Sidney Street, Cambridge, MA 02139 U.S.A. (“Idera”), and Vivelix Pharmaceuticals, LTD., a Bermuda exempted company having a place of business at Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda (“Vivelix”). Vivelix and Idera may be referred to herein individually as a “Party” or collectively as the “Parties.”
